Found: 1
Select item for more details and to access through your institution.
A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell type.
- Published in:
- Oncology Letters, 2016, v. 11, n. 3, p. 1685, doi. 10.3892/ol.2016.4111
- By:
- Publication type:
- Article